Company Filing History:
Years Active: 2020-2024
Title: Innovations of Chunpu Li in Medicinal Chemistry
Introduction
Chunpu Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of chemical compounds that have potential applications in cancer treatment. With a total of 2 patents to his name, his work is recognized for its innovative approach to pharmacotherapy.
Latest Patents
Chunpu Li's latest patents include two notable inventions. The first patent is for a trans-indoline cyclopropylamine chemical compound, which relates to a method for preparation, pharmaceutical composition, and its use as a lysine-specific demethylase 1 (LSD1) inhibitor. This compound may be utilized in the treatment of cancer, showcasing its potential therapeutic benefits. The second patent involves a fluorinated cyclopropylamine compound, which also serves as an LSD1 inhibitor and is aimed at cancer treatment. This invention includes a preparation method, pharmaceutical compositions, and various forms of the compound, further emphasizing its versatility in medicinal applications.
Career Highlights
Chunpu Li is affiliated with the Chinese Academy of Sciences, where he conducts his research and development work. His position at this esteemed institution allows him to collaborate with other leading scientists and contribute to advancements in medicinal chemistry.
Collaborations
Chunpu Li has worked alongside notable colleagues, including Hong Tao Liu and Jia Tao Li. Their collaborative efforts have likely enhanced the research outcomes and innovation in their respective fields.
Conclusion
Chunpu Li's contributions to medicinal chemistry through his innovative patents highlight his role as a key inventor in the fight against cancer. His work continues to pave the way for new therapeutic options and advancements in pharmacotherapy.